INITIATIVE 4:Develop a Strategy for Behind-the-Counter Drugs

The Food and Drug Administration held a public hearing last month to gather industry views on the merits of increasing behind-the-counter access to drugs. Representatives from the retail pharmacy industry presented arguments in favor of what could become a new drug category drugs whose sale would not call for a doctor's prescription but would require consultation with a pharmacist. Although supermarket

The Food and Drug Administration held a public hearing last month to gather industry views on the merits of increasing behind-the-counter access to drugs.

Register to view the full article